iCad to Present at Rodman & Renshaw 10th Annual Global Investment Conference

Rodman & Renshaw Annual Global Investment Conference

NASHUA, N.H.- iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announced that Ken Ferry, President and Chief Executive Officer and Darlene Deptula-Hicks, Executive Vice President and Chief Financial Officer, will be presenting a corporate update at the Rodman & Renshaw 10th Annual Global Investment Conference on November 10, 2008 at 5:20 p.m. (Eastern time) being held at the New York Palace Hotel in New York City.

The presentation will be webcast live and archived for replay on the “Investors” section of the company’s website at www.icadmed.com.

A live audio webcast of the presentation will also be available and archived for replay at http://wsw.com/webcast/rrshq14/icad.

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). Currently available in more than 2,200 healthcare centers worldwide, iCAD’s solutions aid in the early detection of the most prevalent cancers including breast, colon, prostate and in the future, lung cancer. For more information, call (877) iCADnow or visit www.icadmed.com.